Medtronic plc. · NYSE:MDT
Medtronic — Technical Presentation (April 2018)
15 slides from Medtronic's technical presentation, April 2018
Slide 1: 2017 ACC/AHA/HRS Syncope Guidelines
2017 ACC/AHA/HRS SYNCOPE GUIDELINES
Slide 2: 2017 ACC/AHA/HRS Guideline for Evaluation and Management of Patients With Syncope
2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, and the Heart Rhythm Society Developed in Collaboration With the American College of Emergency P
Slide 3: Evidence Level Definitions – New Descriptors
EVIDENCE LEVEL DEFINITIONS – NEW DESCRIPTORS Note: types of clinical data qualify level of evidence •i.e. “randomized”/ ”non randomized” Source: Shen WK, et al.. J Am Coll Cardiol. 2017. DOI: 10.1016/j.jacc.2017.03.003. 3
Slide 4: Syncope Initial Evaluation
SYNCOPE INITIAL EVALUATION Source: Shen WK, et al.. J Am Coll Cardiol. 2017. DOI: 10.1016/j.jacc.2017.03.003. 4
Slide 5: Characteristics Identifying Patients Most Likely to Have a Cardiac Cause
CHARACTERISTICS IDENTIYING PATIENTS MOST LIKELY TO BE ASSOCIATED WITH A CARDIAC CAUSE Class LOE Recommendation Evaluation of the cause and assessment for the short- and long-term I B-NR morbidity and mortality risk of Syncope are recommended Historical Characteristics Associated with Increased Proba
Slide 6: Characterizing Risk Score of Syncopal Patients
CHARACTERIZING RISK SCORE OF SYNCOPAL PATIENTS Class LOE Recommendation Evaluation of the cause and assessment for the short- and long-term I B-NR morbidity and mortality risk of syncope are recommended Short-term (<30 d) risk factors Long-term (>30d) risk factors Older age (>60yr) Older age (>6
Slide 7: Syncope Evaluation Care Pathway
SYNCOPE EVALUATION CARE PATHWAY After initial evaluation and if cardiac cause is suspected, cardiac monitoring should be performed – Class I Recommendation ICMs should be placed in all patients with infrequent symptoms Source: Shen WK, et al.. J Am Coll Cardiol. 2017. DOI: 10.1016/j.jacc.2017.03
Slide 8: Cardiac Monitoring Recommendations
CARDIAC MONITORING RECOMMENDATIONS Class LOE Recommendation The choice of a specific cardiac monitor should be determined on the I C-EO basis of the frequency and nature of syncope events. To evaluate selected ambulatory patients with syncope of suspected IIa B-R arrhythmic etiology, an ICM can be u
Slide 9: Monitoring Selection Criteria: The Right Device for the Right Patient
MONITORING SELECTION CRITERIA THE RIGHT DEVICE FOR THE RIGHT PATIENT Holter Extended External Loop Mobile Cardiac Insertable Monitors Holters Recorders Telemetry Cardiac Monitors Duration 24 – 48 hrs 2-14 days Up to 1 month ≤3 years Patient Daily Weekly Monthly Monthly Recurrent, Selection symptoms
Slide 10: Class I Cardiac Monitor Selection
Class I Cardiac Class IIa recommendation for recommendation for cardiac monitoring in Monitor both external and patients suspected of Selection insertable cardiac cardiac cause for monitors syncope Patient selection Based on specific Randomized clinical strategies and risk criteria: evidence support
Slide 11: Clear Definitions for Syncope-Related Terms
CLEAR DEFINITIONS FOR SYNCOPE-RELATED TERMS Term Definition/Comments Syncope A symptom that presents with an abrupt, transient, complete loss of consciousness, associated with inability to maintain postural tone, with rapid and spontaneous recovery. The presumed mechanism is cerebral hypoperfusion.
Slide 12: Clear Definitions for Syncope-Related Terms (Continued)
CLEAR DEFINITIONS FOR SYNCOPE-RELATED TERMS (CONTINUED) Term Definition/Comments Noncardiac syncope Syncope due to noncardiac causes which include reflex syncope, OH, volume depletion, dehydration, and blood loss Reflex (neurally Syncope due to a reflex that causes vasodilation, bradycardia, or both
Slide 13: Brief Statement: Medtronic SEEQ Mobile Cardiac Telemetry System
BRIEF STATEMENT MEDTRONIC SEEQ™ MOBILE CARDIAC TELEMETRY SYSTEM Indications The Medtronic SEEQ Mobile Cardiac Telemetry (MCT) System is intended to continuously measure, record, and periodically transmit physiological data. The System is indicated for those patients who require monitoring for the de
Slide 14: Brief Statement: Medtronic Reveal LINQ Insertable Cardiac Monitor
BRIEF STATEMENT MEDTRONIC REVEAL LINQ™ LNQ11 INSERTABLE CARDIAC MONITOR AND PATIENT ASSISTANT Indications Warnings/Precautions REVEAL LINQ™ LNQ11 Insertable Cardiac Monitor REVEAL LINQ™ LNQ11 Insertable Cardiac Monitor The Reveal LINQ Insertable Cardiac Monitor is an implantable Patients with the Re
Slide 15: Brief Statement: MyCareLink Patient Monitor and CareLink Network
BRIEF STATEMENT MEDTRONIC MYCARELINK™ PATIENT MONITOR, MEDTRONIC CARELINK™ NETWORK AND CARELINK™ MOBILE APPLICATION The Medtronic MyCareLink Patient Monitor and the Medtronic CareLink Network are indicated for use in the transfer of patient data from Medtronic implantable cardiac devices. These prod